study Máxima MC

patient experience and wearable usability in acute heart failure: hospital vs home

collaboration with: Maxima Medical Center (Maxima MC), Veldhoven, The Netherlands

Heart failure management often requires frequent monitoring of vital signs to prevent deterioration and ensure timely intervention. This study aims to assess how continuous monitoring devices like viQtor can support clinical decision-making by providing real-time health data, whether in a hospital setting or from the comfort of home. By understanding patient preferences and the usability of these devices, the study seeks to inform future approaches to heart failure management and improve health outcomes.

study overview & objective

This study, conducted by Maxima MC, focuses on patient satisfaction and experiences with hospital-based versus home-based care for individuals with acute decompensated heart failure. Central to the study is an evaluation of the usability and reliability of two wearable devices: the wrist-worn Cardiac Sense watch and smartQare’s upper-arm PPG sensor, viQtor.

study design and participants

key participants: 

• 50 patients with acute decompensated heart failure (25 receiving hospital care, 25 receiving home care).

study duration

• Hospital start: June 2024.
• Home start: October 2024.
• Duration: 6 months.
• Status: Ongoing

expected results and benefits

Results, expected in Q2 2025, will provide valuable insights into the usability and patient satisfaction of wearable monitoring devices in different care settings. These findings have the potential to influence future practices in heart failure management by highlighting the role of continuous, real-time monitoring in delivering proactive and personalized care. The study’s outcomes will contribute to advancing evidence-based approaches to remote patient monitoring and optimizing care pathways for heart failure patients.